These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17500)

  • 21. Disposition of acetylmethadol in relation to pharmacologic action.
    Kaiko RF; Inturrisi CE
    Clin Pharmacol Ther; 1975 Jul; 18(1):96-103. PubMed ID: 238782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New gas chromatogrphic assay for the quantification of methadone. Application in human and animal studies.
    Lynn RK; Leger RM; Gordon WP; Olsen GD; Gerber N
    J Chromatogr; 1977 Jan; 131():329-40. PubMed ID: 856855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary excretion of methadone by the rat: identification of a para-hydroxylated major metabolite.
    Baselt RC; Bickel MH
    Biochem Pharmacol; 1973 Dec; 22(23):3117-20. PubMed ID: 4761568
    [No Abstract]   [Full Text] [Related]  

  • 24. Craving despite extremely high methadone dosage.
    de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
    Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment.
    Verebely K; Volavka J; Mulé S; Resnick R
    Clin Pharmacol Ther; 1975 Aug; 18(2):180-90. PubMed ID: 1149368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of methadone and metabolite in patients under maintenance treatment.
    Diong SH; Mohd Yusoff NS; Sim MS; Raja Aziddin RE; Chik Z; Rajan P; Abdul Rashid R; Chemi N; Mohamed Z
    J Anal Toxicol; 2014; 38(9):660-6. PubMed ID: 25106416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal clearance of sulphinpyrazone in man.
    Lentjes EG; Russel FG; van Ginneken CA
    Eur J Clin Pharmacol; 1986; 31(4):473-8. PubMed ID: 3816927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain.
    Inturrisi CE; Colburn WA; Kaiko RF; Houde RW; Foley KM
    Clin Pharmacol Ther; 1987 Apr; 41(4):392-401. PubMed ID: 3829576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
    Adelson M; Peles E; Bodner G; Kreek MJ
    J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoking and methadone dose levels.
    Stark MJ; Campbell BK
    Am J Drug Alcohol Abuse; 1993; 19(2):209-17. PubMed ID: 8484357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-Methadone and D,L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations.
    de Vos JW; Ufkes JG; Kaplan CD; Tursch M; Krause JK; van Wilgenburg H; Woodcock BG; Staib AH
    Eur Addict Res; 1998 Sep; 4(3):134-41. PubMed ID: 9742275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of diazepam on the metabolism of methadone by the liver of methadone-dependent rats.
    Spaulding TC; Minium L; Kotake AN; Takemori AE
    Drug Metab Dispos; 1974; 2(5):458-63. PubMed ID: 4156309
    [No Abstract]   [Full Text] [Related]  

  • 33. Transformation of methadone and its main human metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), during water chlorination.
    González-Mariño I; Quintana JB; Rodríguez I; Cores M; Cela R
    Water Res; 2015 Jan; 68():759-70. PubMed ID: 25462780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary secretion of methadone and methadone metabolites in man.
    Kreek MJ; Kalisman M; Irwin M; Jaffery NF; Scheflan M
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):67-78. PubMed ID: 7403680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Important clinical pharmacologic considerations in the use of methadone in cancer patients.
    Ettinger DS; Vitale PJ; Trump DL
    Cancer Treat Rep; 1979 Mar; 63(3):457-9. PubMed ID: 427826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone maintenance: an assessment of potential fluctuations in behavior between doses.
    Kelley D; Welch R; McKnelley W
    Int J Addict; 1978 Oct; 13(7):1061-8. PubMed ID: 721344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone plasma level: sustained by a reservoir of drug in tissue.
    Dole VP; Kreek MJ
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):10. PubMed ID: 4509643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone maintenance: plasma levels and therapeutic outcome.
    Holmstrand J; Anggård E; Gunne LM
    Clin Pharmacol Ther; 1978 Feb; 23(2):175-80. PubMed ID: 620477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.